Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
52 studies found for:    University of Kentucky | Alzheimer's disease | United States, Kentucky
Show Display Options
Rank Status Study
1 Active, not recruiting Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Condition: Preclinical Alzheimer's Disease
Interventions: Drug: Gemfibrozil;   Drug: Placebo
2 Completed Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study
Condition: Alzheimer's Disease
Interventions: Drug: Valproic Acid;   Drug: Placebo
3 Completed Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
Condition: Alzheimer's Disease
Intervention:
4 Recruiting The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
Conditions: Alzheimer's Disease;   Dementia
Interventions: Other: Placebo;   Other: Medication Therapy Management (MTM);   Drug: Scopolamine patch
5 Active, not recruiting A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly
Condition: Alzheimer Disease
Intervention: Other: Arm 1 Education Session
6 Unknown  Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
7 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
8 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
9 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
10 Recruiting A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3314814;   Drug: Placebo
11 Recruiting SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Condition: Alzheimer's Disease
Interventions: Drug: SUVN-502;   Drug: Placebo
12 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
13 Completed
Has Results
Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
14 Active, not recruiting A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: AZD0530 100mg daily;   Drug: AZD0530 125mg daily;   Drug: Placebo
15 Completed Anti-Oxidant Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Vitamin E, Vitamin C, and Alpha-lipoic Acid;   Drug: Coenzyme Q;   Drug: Placebo capsules;   Drug: Placebo wafers
16 Completed ADNI: Alzheimer's Disease Neuroimaging Initiative
Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Positron Emission Tomography (PET);   Procedure: Lumbar Puncture (LP)
17 Completed A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Condition: Alzheimer Disease
Interventions: Drug: Rofecoxib;   Drug: Naproxen
18 Completed Agitation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Trazodone;   Drug: Haloperidol
19 Recruiting Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD)
Intervention:
20 Completed Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.